Edgewise Therapeutics
EWTX
EWTX
214 hedge funds and large institutions have $3.72B invested in Edgewise Therapeutics in 2026 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 65 increasing their positions, 66 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
8% more funds holding
Funds holding: 199 → 214 (+15)
2% less repeat investments, than reductions
Existing positions increased: 65 | Existing positions reduced: 66
4.57% less ownership
Funds ownership: 115.07% → 110.5% (-4.6%)
Holders
214
Holding in Top 10
11
Calls
$18.7M
Puts
$11.1M
Top Buyers
| 1 | +$38.9M | |
| 2 | +$23.8M | |
| 3 | +$19.8M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$15.6M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$15.3M |
Top Sellers
| 1 | -$82.6M | |
| 2 | -$23.2M | |
| 3 | -$19.2M | |
| 4 |
DM
Deerfield Management
New York
|
-$19M |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$16.5M |
